Frontiers: University of Kansas Clinical and Translational Science Institute

前沿：堪萨斯大学临床与转化科学研究所

• 批准号: 10474055
• 负责人: Mario Castro
• 金额: $ 121.15万
• 依托单位: UNIVERSITY OF KANSAS MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-07 至 2022-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10474055
• 关键词: Academia; Address; Advocacy; Advocate; African American; American Indians; Automobile Driving; Award; Birth; Childhood; Cities; Clinic; Clinical; Clinical Research; Clinical Sciences; Collaborations; Communities; Competence; Complex; Data; Data Analyses; Decision Making; Development; Discipline; Disease; Elderly; Electronic Health Record; Ensure; Entrepreneurship; Ethics; Funding; Generations; Goals; Good Clinical Practice; Government; Health; Health Sciences; Healthcare; Individual; Industry; Informatics; Information Dissemination; Infrastructure; Institutes; Institution; Institutional Review Boards; Interdisciplinary Study; Kansas; Knowledge; Latino; Lead; Leadership; Lesbian Gay Bisexual Transgender Queer; Link; Longevity; Medical; Medical Device; Medical Informatics; Medical center; Methods; Midwestern United States; Participant; Patient Recruitments; Patients; Pharmaceutical Preparations; Pilot Projects; Population Heterogeneity; Positioning Attribute; Process; Rare Diseases; Registries; Research; Research Design; Research Infrastructure; Research Personnel; Research Support; Research Training; Resource Informatics; Resources; Rural Population; Science; Scientific Advances and Accomplishments; Texas; Training; Training Programs; Translating; Translational Research; Universities; Vision; Workforce Development; base; catalyst; clinical care; community engagement; community partnership; drug discovery; end of life; frontier; implementation research; improved; industry partner; informatics tool; innovation; multi-site trial; multidisciplinary; next generation; novel; novel strategies; patient engagement; patient oriented; point of care; population health; precision medicine; prison population; product development; programs; recruit; service organization; support tools; tool

Project Abstract Local health departments are employing widely varying approaches to address the dramatic health inequities associated with the COVID-19 pandemic. Learning collaboratives have been effective in other settings for bringing entities together to support joint problem solving and reduce variance in approach. These collaboratives build upon shared experiences to help their members understand not only what to do but how to do it, providing knowledge and skills that are critical to successful implementation of interventions. This study aims to examine the effectiveness of a diverse, regional learning collaborative of health departments that will rapidly adapt, test, and implement community-driven solutions for COVID testing disparities using a pragmatic, hybrid type II trial design. Based on preliminary data from a community-led approach developed in a severely affected Kansas county (Wyandotte), the project will build Local Heath Equity Action Teams in 10 counties (4 urban and 6 rural) disproportionately affected by COVID and provide them with the training and resources needed to achieve COVID testing equity. These Local Health Equity Action Teams will come together into a multi-jurisdictional learning collaborative or `Community Partner Program' (Aim 1) that can share best practices and collaborate on developing, testing and evaluating multi-component intervention packages for addressing COVID. Initial supported interventions will include: community-sponsored pop-up testing events; home-based and worksite testing; community-informed communication strategies; and `support packages' for at-risk individuals and families receiving testing. Additional interventions developed or proposed by our local community partners or identified through national RADx-UP efforts will be continuously considered by the collaborative. Working with the local Action teams, we will conduct a series of semi-structured interviews and surveys within each local community (Aim 2) to better understand common and subgroup (racial, ethnic, geographic, etc.) barriers to and facilitators of testing. We will leverage existing epidemiologic surveillance tools to develop and track a series of county-level metrics of COVID testing inequities. Guided by the RE-AIM framework and the Consolidated Framework for Intervention Research, we will examine the effectiveness (Aim 3) of the collaborative in improving uptake of COVID testing in vulnerable communities and examine the reach, adoption, implementation and maintenance of intervention components within each local community. This study will not only advance our understanding of how to achieve COVID testing equity but will also provide a framework for supporting underserved communities as they respond to future public health emergencies and COVID vaccination challenges.

项目摘要 当地卫生部门正在采用广泛不同的方法来解决戏剧性的健康不平等现象 与COVID-19的大流行有关。学习协作在其他环境中有效 将实体汇集在一起​​，以支持解决联合问题并减少方法的差异。这些 协作基于共同的经验，以帮助其成员不仅了解该怎么做，而且了解如何做 这样做，提供对成功实施干预措施至关重要的知识和技能。这项研究 旨在研究卫生部门的各种区域学习合作的有效性 快速适应，测试和实施社区驱动的解决方案，用于使用务实的务实测试差异， 混合II型试验设计。基于来自社区主导的方法的初步数据 受影响的堪萨斯县（Wyandotte），该项目将在10个县建立当地的荒地股权行动团队（4个 城市和6个农村）受到共同影响不成比例的，并为他们提供培训和资源 需要实现共同测试权益。这些当地的健康公平行动团队将聚集在一起 可以分享最佳实践的多界数学学习合作或“社区合作伙伴计划”（AIM 1） 并协作开发，测试和评估用于解决的多组分干预软件包 冠状病毒。初始支持的干预措施将包括：社区赞助的弹出式测试事件；基于家庭 和工作场所测试；社区信息的沟通策略；和高风险的“支持软件包” 接受测试的个人和家庭。我们当地制定或提出的其他干预措施 社区合作伙伴或通过国家RADX-UP努力确定的将不断考虑 协作。与当地行动团队合作，我们将进行一系列半结构化访谈，并 每个当地社区内的调查（目标2），以更好地了解共同和亚组（种族，种族， 地理等）测试的障碍和促进者。我们将利用现有的流行病学监测 开发和跟踪一系列县级县级测试不平等的县级指标的工具。由Re-Aim引导 框架和干预研究的合并框架，我们将研究有效性（目标 3）合作组织改善了弱势社区的共同测试的吸收，并检查了覆盖范围， 每个地方社区内的干预组件的采用，实施和维护。这 研究不仅会促进我们对如何实现共同测试公平的理解，还将提供一个 支持未来公共卫生紧急情况和 共同疫苗接种挑战。